Africa CDC’s Post

View organization page for Africa CDC, graphic

123,785 followers

Special Briefing on Mpox |Aug 27 2024 Mpox is a zoonotic disease caused by a double-stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family. The disease presents with symptoms similar to smallpox but with a lesser severity. It was first discovered in 1958 when two outbreaks of a poxlike disease occurred in colonies of monkeys kept for research, hence the name ‘mpox. The first human case of mpox was recorded in 1970 in the Democratic Republic of the Congo (DRC), which has subsequently spread to other central and western African countries. There are two known clades of the virus: clade I and clade II. Clade I, which is most frequently reported from countries in Central Africa, tends to be more severe than clade II. Cameroon is the only country known to harbour both clades.

Special Briefing on Mpox |Aug 27 2024

Special Briefing on Mpox |Aug 27 2024

www.linkedin.com

Well Done Africa CDC and other collaborators. It is always better to plan well than not planning while getting ready to implement the laid down strategies in time and also give room for adjustment where necessary. We can get ready for the preventions against the known mode of transmission which is better to minimise the number of +ve cases that may come up. Quality Active case search is key with solid data management tools. I dropped my cap.

Like
Reply
Sherine Shawky

Public affairs and commercial lead ( Vaccines)🇪🇬

2mo

Great effort from African CDC , Unicef and WHO to support the countries at risk to fight against MPox

Victor Siinda

Medical Laboratory Scientist | MBA

2mo

Well is there anything being done to empower and capacitate those few selected African vaccine manufacturing companies to scale up on the amount vaccines in the mpox affected regions

Like
Reply

This is great and in order. Preventions are better if only if they are well planned. and

Mohammed Ahmed Teka

Field Epidemiologist / Public Health Professional (Dual MPH in Field Epidemiology and General Public Health)

2mo

I have reviewed the East African case report, and it appears that there may be significant underreporting concerning the vulnerability of the East African communities. I am interested in learning more about the situation analysis regarding East Africa's Mpox preparedness and the integrity of its reporting systems in relation to the applied epidemiological ethics.

Like
Reply
Polydor N Mutombo

Public Health Epidemiologist | The World Bank | National Centre for Naturopathic Medicine, Faculty of Health, Southern Cross University

2mo

From lesson learned from Covid-19 vaccine hesitancy and growing infodemie already going on against Mpox vaccine : what is the plan? Dr Polydor Mutombo (Australia)

Like
Reply

This is great for the Mpox preventions as we ensure all the likely mode of infections are taken care of. I salute all the think tank individuals and groupsfrom Nigeria

Like
Reply

Teta might have a positive impact on Mpox . I wrote a post about it. Shall we find better solutions against Mpox? then contact

Like
Reply
George Nyandoro

Medical Statistics, Epidemiology & Control of Infectious Diseases (HIV/TB, Malaria, STIs, Covid 19) and Non-communicable Diseases(NCDs)

2mo

Joining from Louisiana, USA

Like
Reply
George Nyandoro

Medical Statistics, Epidemiology & Control of Infectious Diseases (HIV/TB, Malaria, STIs, Covid 19) and Non-communicable Diseases(NCDs)

2mo

Thanks for timely planning, emergency responses to those countries affected and wide advocacy for global response

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics